Jet Edge announced this week that it has entered into an agreement with Cue Health, a first of its kind in the industry. Cue Health will provide all Jet Edge flight crews and global teams routine access to real-time COVID-19 molecular self-testing with instant results. Jet Edge is the first private aircraft operator to adopt a molecular self-testing solution, a game-changer for the industry.
The Cue test uses nucleic acid amplification technology to provide lab-quality COVID-19 test results from any location in 20 minutes. Based on current clinical studies submitted to the FDA, it is the most accurate self-test for COVID-19 and can detect all known COVID-19 variants, including Omicron. Cue’s lab results are directly connected to mobile devices so that critical safety information can be easily accessed and acted on immediately. The test can be used on adults and children over 2 years, with or without symptoms.
“Cue’s breakthrough testing technology allows Jet Edge to further our commitment to the health and safety of our passengers and crews,” said Jonah Adler, Chief Commercial Officer of Jet Edge. “Rather than relying on ever-changing messages from guideline groups, we are now giving each of our employees their own Cue reader and cartridge for daily testing. Their results are fast and actionable. Knowing who is positive and negative each morning greatly lessens our logistical challenges and keeps our passengers and employees even safer.”